The ubiquitin-proteasome pathway is responsible for the degradation of most cellular proteins in eukaryotes.It regulates almost all cellular activities, including cell proliferation, differentiation, apoptosis, gene transcription, and DNA repair.The dysfunction of the ubiquitin-proteasome pathway is associated with the pathogenesis of numerous human diseases, including cancer and neurodegenerative diseases.The marketed proteasome inhibitors have been successfully used to treat multiple myeloma and mantle cell lymphoma.Furthermore, novel inhibitors against the components of the ubiquitin-proteasome pathway are under developed and exhibit promising therapeutic effects in vivo.This paper will briefly introduce the progress on the drug discovery related to the ubiquitin-proteasome pathway.

Objective To systematically analyze the literature on ABO-incompatible(ABOi)organ transplantation and explore the research hotspots and trends in this field.Methods CiteSpace software was used for visual analysis of ABOi organ transplantation literature collected from the China National Knowledge Infrastructure,VIP web,Wanfang Data,and the Web of Science Core Collection database from January 1,2013 to December 31,2023 after cleaning,including the volume of literature published,authors,countries,institution and keywords.Results A total of 588 valid foreign-language author publications and 85 valid Chinese-language author publications were included.Since 2021,the volume of foreign literature publications has shown a downward trend,while the volume of domestic literature published has generally shown a upward trend.The top two core Chinese authors are Wang Yi and Zhu Zhijun;the top three core authors in foreign literature are Nakatani Tatsuya,Tanabe Kazunari,and Uchida Junji.The most active institution in China is Huazhong University of Science and Technology,followed by Zhejiang University and Sichuan University,with relatively insufficient closeness in cooperation between related institutions.The institutions with the most publications abroad are Ulsan University,Seoul National University and Tokyo Women's Medical University in Japan.The top three countries in English-language literature publications are Japan,Republic Korea,and the United States,and China ranked 5th.Keyword cluster analysis shows that the research focus of at home and abroad is mainly on nine topic clusters including ABOi organ transplantation,cryoprecipitation,kidney transplantation,liver transplantation,blood type antigen detection technology and post-transplant complications.Conclusions At present,The research in the field of ABOi organ transplantation is mainly concentrated on kidney transplantation and liver transplantation,showing an overall positive development trend.In the future,it is expected to further promote development of this field by strengthening international cooperation,expanding research investment and promoting the application of advanced technologies.

Hypercoagulable state (HCS) after kidney transplantation is one of the common and serious complications in kidney transplant recipients, which has attracted increasing attention in recent years. HCS refers to the abnormal and excessive activation of blood coagulation function, leading to the increased risk of thrombosis. After kidney transplantation, the combined effects of hemodynamic changes, surgical trauma and severe rejection increase the incidence of HCS, not only raising the risk of thrombosis but also potentially causing graft failure and affecting the postoperative survival rate of patients. This article reviews the influencing factors, clinical manifestations, diagnostic methods and preventive strategies of HCS after kidney transplantation, aiming to provide a theoretical basis for optimizing perioperative management and improving the prognosis of patients.

Humans ; HIV-1/genetics* ; Anti-Retroviral Agents/therapeutic use* ; Mutation/genetics* ; Treatment Failure ; HIV Infections/genetics* ; Drug Resistance, Viral/genetics* ; Anti-HIV Agents/therapeutic use* ; Genotype